Management

Neurotrophic keratopathy management depends on the severity of the ocular surface condition and the degree of sensory denervation. Sensory denervation increases the longer the ocular surface disease exists on the eye. Treatment should be based on not only subjective symptoms reported by the patient but, more importantly, in lieu of symptoms, based on objective findings. Stage 1 neurotrophic keratopathy can be treated with aggressive topical lubricants such as preservative-free artificial tears, gels, and ointments. Eyelid abnormalities such as MGD and blepharitis must be carefully assessed and treated so that exposure keratopathy (corneal surface defects) does not progress to stage 2 neurotrophic keratopathy. Later stages of this disease may require punctual occlusion to increase the tear volume as well as amniotic membranes to help heal the corneal epithelial defects.